These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27546878)

  • 1. The neurocircuitry involved in oxytocin modulation of methamphetamine addiction.
    Baracz SJ; Cornish JL
    Front Neuroendocrinol; 2016 Oct; 43():1-18. PubMed ID: 27546878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus.
    Carson DS; Hunt GE; Guastella AJ; Barber L; Cornish JL; Arnold JC; Boucher AA; McGregor IS
    Addict Biol; 2010 Oct; 15(4):448-63. PubMed ID: 20731630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Methamphetamine Self-Administration Dysregulates Oxytocin Plasma Levels and Oxytocin Receptor Fibre Density in the Nucleus Accumbens Core and Subthalamic Nucleus of the Rat.
    Baracz SJ; Parker LM; Suraev AS; Everett NA; Goodchild AK; McGregor IS; Cornish JL
    J Neuroendocrinol; 2016 Apr; 28(4):. PubMed ID: 26563756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamine-induced conditioned place preference.
    Baracz SJ; Rourke PI; Pardey MC; Hunt GE; McGregor IS; Cornish JL
    Behav Brain Res; 2012 Mar; 228(1):185-93. PubMed ID: 22155611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin in the nucleus accumbens core reduces reinstatement of methamphetamine-seeking behaviour in rats.
    Baracz SJ; Everett NA; McGregor IS; Cornish JL
    Addict Biol; 2016 Mar; 21(2):316-25. PubMed ID: 25399704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin Acts in Nucleus Accumbens to Attenuate Methamphetamine Seeking and Demand.
    Cox BM; Bentzley BS; Regen-Tuero H; See RE; Reichel CM; Aston-Jones G
    Biol Psychiatry; 2017 Jun; 81(11):949-958. PubMed ID: 28110822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Involvement of Oxytocin in the Subthalamic Nucleus on Relapse to Methamphetamine-Seeking Behaviour.
    Baracz SJ; Everett NA; Cornish JL
    PLoS One; 2015; 10(8):e0136132. PubMed ID: 26284529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of vasopressin and oxytocin on methamphetamine-induced place preference behaviour in rats.
    Subiah CO; Mabandla MV; Phulukdaree A; Chuturgoon AA; Daniels WM
    Metab Brain Dis; 2012 Sep; 27(3):341-50. PubMed ID: 22447521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxytocin modulates dopamine-mediated reward in the rat subthalamic nucleus.
    Baracz SJ; Cornish JL
    Horm Behav; 2013 Feb; 63(2):370-5. PubMed ID: 23238104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of dopamine D₂ receptors in the nucleus accumbens core suppresses methamphetamine-induced behaviors and signal transduction in mice.
    Miyamoto Y; Iida A; Sato K; Muramatsu S; Nitta A
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compulsive methamphetamine taking in the presence of punishment is associated with increased oxytocin expression in the nucleus accumbens of rats.
    Krasnova IN; Gerra MC; Walther D; Jayanthi S; Ladenheim B; McCoy MT; Brannock C; Cadet JL
    Sci Rep; 2017 Aug; 7(1):8331. PubMed ID: 28827541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats.
    Broom SL; Yamamoto BK
    Psychopharmacology (Berl); 2005 Sep; 181(3):467-76. PubMed ID: 15986185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of maternal separation and methamphetamine exposure on protein expression in the nucleus accumbens shell and core.
    Dimatelis JJ; Russell VA; Stein DJ; Daniels WM
    Metab Brain Dis; 2012 Sep; 27(3):363-75. PubMed ID: 22451087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.
    Godino A; Jayanthi S; Cadet JL
    Epigenetics; 2015; 10(7):574-80. PubMed ID: 26023847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
    Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
    J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of activated astrocytes in the development of drug dependence: differences between methamphetamine and morphine.
    Narita M; Suzuki M; Kuzumaki N; Miyatake M; Suzuki T
    Ann N Y Acad Sci; 2008 Oct; 1141():96-104. PubMed ID: 18991953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
    Shoblock JR; Sullivan EB; Maisonneuve IM; Glick SD
    Psychopharmacology (Berl); 2003 Feb; 165(4):359-69. PubMed ID: 12491026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats.
    Carson DS; Cornish JL; Guastella AJ; Hunt GE; McGregor IS
    Neuropharmacology; 2010 Jan; 58(1):38-43. PubMed ID: 19560473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trace amine-associated receptor 1: A promising target for the treatment of psychostimulant addiction.
    Jing L; Li JX
    Eur J Pharmacol; 2015 Aug; 761():345-52. PubMed ID: 26092759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration.
    Wee S; Wang Z; Woolverton WL; Pulvirenti L; Koob GF
    Neuropsychopharmacology; 2007 Oct; 32(10):2238-47. PubMed ID: 17327886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.